Xenon Pharmaceuticals is a clinical-stage biopharma company developing ion channel–targeted therapies for epilepsy and other neurological disorders. Its treatments aim to reduce seizures and improve quality of life for patients with hard-to-treat conditions, benefiting individuals and families affected by these disorders.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends